Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Search content at Arizona State University
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
Oral & Mucosal Adjuvant as an Immunostimulant Against HIV
Charles Arntzen (Inventor)
Arizona State University
Research output
:
Patent
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Oral & Mucosal Adjuvant as an Immunostimulant Against HIV'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Mucosal Adjuvant
100%
Immunostimulant
100%
Cholera Toxin B
100%
Oral Adjuvant
100%
Oral mucosa
100%
Immunostimulatory
66%
Arizona State University
33%
Immune Response
33%
Effective Alternative
33%
Safer Alternatives
33%
Immunogenic
33%
Immunogenicity
33%
Orally Active
33%
Epithelial Cells
33%
Oral Ingestion
33%
Lectin
33%
Mucosal Immune Response
33%
Live Attenuated
33%
Transgenic Plants
33%
Mucosal Vaccine
33%
Oral Immunotherapy
33%
High Titer
33%
Transcytosis
33%
Active Peptide
33%
Edible Tissues
33%
Subunit Vaccine
33%
α-galactosylceramide (α-GalCer)
33%
Mucosal Epithelial Cells
33%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Cholera Toxin B Subunit
100%
Immunostimulant
100%
Subunit Vaccine
66%
Death
66%
Infectious Agent
33%
Adjuvant
33%
Immunogenicity
33%
Lectin
33%
Transgenic Plant
33%
Mucosal Vaccine
33%
Transcytosis
33%
Galactosylceramide
33%
Diseases
33%
Immunology and Microbiology
Human Immunodeficiency Virus
100%
Immunostimulant
100%
Peptides
100%
Cholera Toxin
33%
Subunit Vaccine
33%
Infectious Agent
16%
Immune Response
16%
Immunogenicity
16%
Adjuvant
16%
Lectin
16%
Mucosal Immune System
16%
Titer
16%
Transgenic Plant
16%
Ingestion
16%
Cholera Vaccine
16%
Transcytosis
16%
Medicine and Dentistry
Transcytosis
33%